Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Recurrent MSC E116K mutations in ALK-negative anaplastic large cell lymphoma

Blood (2019) 133 (26): 2776–2789.

https://doi.org/10.1182/blood.2019000626

Published: 2019

Includes: Supplemental data

Journal Articles

Robust Assessment of Genomic Imbalance in Diffuse Large B-Cell Lymphoma Confirms Inferior Outcome Is Associated with Genomic Complexity and Identifies Potential Therapeutic Pathway Targets

Lizalynn Dias, PhD, Venkata Thodima, PhD, Asha Guttapalli, M.S., Geetu Mendiratta, PhD, Sergei I Syrbu, MD, Jane Houldsworth, PhD

Blood (2014) 124 (21): 2993.

https://doi.org/10.1182/blood.V124.21.2993.2993

Published: 2014

Journal Articles

Event-Free Survival at 12 Months (EFS12) from Diagnosis Is a Robust Endpoint for Disease-Related Survival in Patients with Follicular Lymphoma in the Immunochemotherapy Era

Blood (2014) 124 (21): 1664.

https://doi.org/10.1182/blood.V124.21.1664.1664

Published: 2014

Journal Articles

IPI24: An International Study To Create An IPI For The Event-Free Survival At 24 Months (EFS24) Endpoint For DLBCL In The Immunochemotherapy Era

Blood (2013) 122 (21): 362.

https://doi.org/10.1182/blood.V122.21.362.362

Published: 2013

Journal Articles

EBV(+) Diffuse Large B Cell Lymphoma Is Infrequent in Upper Central United States and Lacks Unique Clinical Characteristics or Adverse Prognosis Compared to EBV (−) Counterparts: Results From University of Iowa/Mayo Clinic SPORE

Usha Perepu, MBBS, Ahmet Dogan, MD, PhD, Matthew J Maurer, MS, Cristine Allmer, BS, Carrie A. Thompson, MD, Stephen M Ansell, Sergei I Syrbu, MD, Susan L Slager, PhD, Thomas E. Witzig, MD, George J. Weiner, MD, Thomas M. Habermann, James R Cerhan, MD, PhD, Brian K Link, MD

Blood (2012) 120 (21): 1604.

https://doi.org/10.1182/blood.V120.21.1604.1604

Published: 2012

Journal Articles

Non-Follicular Low Grade B-Cell Lymphomas: Patterns of Presentation and Management with Comparative Prognostic Utility of IPI and FLIPI

Laura S. Jacobus, MS, Julianne Lunde, MA, Matthew J Maurer, MS, Ahmet Dogan, MD, PhD, Sergei I Syrbu, MD, Cristine Allmer, Anne J. Novak, Ph.D., James R Cerhan, MD, PhD, Grzegorz S. Nowakowski, MD, Susan L Slager, PhD, Thomas E. Witzig, MD, Carrie A. Thompson, MD, George J. Weiner, MD, Thomas M Habermann, MD, Stephen M. Ansell, M.D., Ph.D., Brian K Link, MD

Blood (2012) 120 (21): 1563.

https://doi.org/10.1182/blood.V120.21.1563.1563

Published: 2012

Journal Articles

Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients Treated with Immunochemotherapy Who Are Alive and Progression Free 12 Months After Diagnosis Have a Subsequent Overall Survival Similar to That of the General Population

Matthew J Maurer, MS, Herve Ghesquieres, MD, PhD, Thomas E. Witzig, MD, Carrie A. Thompson, MD, Ivana N. Micallef, MD, William R Macon, MD, Sergei I Syrbu, MD, Paul Kurtin, MD, Cristine Allmer, BS, Therese Gargi, Emmanuelle Nicolas-Virelizier, MD, Catherine Sebban, MD, Susan L Slager, PhD, Thomas M Habermann, MD, Brian K Link, MD, James R Cerhan, MD, PhD

Blood (2012) 120 (21): 1540.

https://doi.org/10.1182/blood.V120.21.1540.1540

Published: 2012

Journal Articles

Rates and Outcomes of Follicular Lymphoma Transformation in the Rituximab Era: A Report From the University of Iowa/Mayo Clinic SPORE Molecular Epidemiology Resource

Brian K Link, MD, Matthew J Maurer, MS, Grzegorz S. Nowakowski, MD, Stephen M Ansell, MD, PhD, William R Macon, MD, Sergei I Syrbu, MD, Susan L Slager, PhD, Carrie A. Thompson, MD, David J. Inwards, MD, Patrick B. Johnston, MD, PhD, Joseph P. Colgan, MD, Thomas E. Witzig, MD, George J Weiner, Thomas M. Habermann, James R Cerhan, MD, PhD

Blood (2012) 120 (21): 1546.

https://doi.org/10.1182/blood.V120.21.1546.1546

Published: 2012

Journal Articles

Elevated Monoclonal Free Light Chains Are a Serum Marker of ABC Type Diffuse Large B-Cell Lymphoma

Matthew J Maurer, MS, James R Cerhan, MD, PhD, Jerry A Katzmann, PhD, Ahmet Dogan, M.D., Ph.D., Mamta Gupta, Ph.D, William R Macon, MD, Sergei I Syrbu, MD, Brian K Link, MD, Ivana N. Micallef, MD, Thomas E Witzig

Blood (2011) 118 (21): 1591.

https://doi.org/10.1182/blood.V118.21.1591.1591

Published: 2011

Journal Articles

Thymidylate Synthase (TS) Expression In Diffuse Large B-Cell Lymphoma (DLBCL): Identification of a Potential Therapeutic Target

Emilian Racila, Sergei I Syrbu, MD, Michel Nasr, MD, Malik E. Juweid, MD

Blood (2010) 116 (21): 5107.

https://doi.org/10.1182/blood.V116.21.5107.5107

Published: 2010

Journal Articles

Elevation of Serum Free Light Chains Are Common In Lymphoma and Associated with Poor Event Free and Overall Survival

Matthew J Maurer, James Cerhan, MD, PhD, Jerry A Katzmann, PhD, Brian Link, Ivana N Micallef, MD, Joseph Colgan, MD, Thomas M. Habermann, MD, David James Inwards, MD, Svetomir Markovic, MD, PhD, Stephen M. Ansell, MD, PhD, Luis Porrata, MD, Patrick B Johnston, MD, Grzegorz S. Nowakowski, MD, Carrie A Thompson, MD, Mamta Gupta, Ph.D, Sergei I Syrbu, MD, Paul Kurtin, MD, William Macon, MD, Thomas E. Witzig, MD

Blood (2010) 116 (21): 4136.

https://doi.org/10.1182/blood.V116.21.4136.4136

Published: 2010

Journal Articles

Genetic Polymorphisms In Genes Involved In R-CHOP Metabolism and Event-Free and Overall Survival In Diffuse Large B-Cell Lymphoma

James R Cerhan, MD, PhD, Thomas M Habermann, MD, Matthew J Maurer, MS, James E Wooldridge, MD, Stephen M Ansell, MD, PhD, Grzegorz S. Nowakowski, MD, Ivana N Micallef, MD, Carrie A Thompson, MD, Alice H Wang, BA, William R Macon, MD, Sergei I Syrbu, MD, Susan L Slager, PhD, Thomas E Witzig, MD, Brian Link

Blood (2010) 116 (21): 996.

https://doi.org/10.1182/blood.V116.21.996.996

Published: 2010

Journal Articles

Association of Increased Thymidine Uptake Relative to Tumor Cell Proliferation in Low-Grade Follicular Lymphoma and DNA Repair.

Malik E. Juweid, MD, Sergei I. Syrbu, Michelle Bleile, Andreas Buck, Marielle Wondergem, MD, Julie M. Vose, M.D.

Blood (2009) 114 (22): 3236.

https://doi.org/10.1182/blood.V114.22.3236.3236

Published: 2009

Journal Articles

Diffuse Large B-Cell Lymphoma (DLBCL) Patients with Composite Histology Have Improved Early Outcome Compared to De Novo DLBCL When Treated with R-CHOP

Matthew J. Maurer, Thomas E. Witzig, William R. Macon, Sergei I. Syrbu, James R. Cerhan, Cristine Allmer, Patrick B. Johnston, Brian K. Link, Thomas M. Habermann

Blood (2008) 112 (11): 2819.

https://doi.org/10.1182/blood.V112.11.2819.2819

Published: 2008

NARROW

Recurrent MSC E116K mutations in ALK-negative anaplastic large cell lymphoma

Robust Assessment of Genomic Imbalance in Diffuse Large B-Cell Lymphoma Confirms Inferior Outcome Is Associated with Genomic Complexity and Identifies Potential Therapeutic Pathway Targets

Event-Free Survival at 12 Months (EFS12) from Diagnosis Is a Robust Endpoint for Disease-Related Survival in Patients with Follicular Lymphoma in the Immunochemotherapy Era

IPI24: An International Study To Create An IPI For The Event-Free Survival At 24 Months (EFS24) Endpoint For DLBCL In The Immunochemotherapy Era

EBV(+) Diffuse Large B Cell Lymphoma Is Infrequent in Upper Central United States and Lacks Unique Clinical Characteristics or Adverse Prognosis Compared to EBV (−) Counterparts: Results From University of Iowa/Mayo Clinic SPORE

Non-Follicular Low Grade B-Cell Lymphomas: Patterns of Presentation and Management with Comparative Prognostic Utility of IPI and FLIPI

Newly Diagnosed Diffuse Large B-Cell Lymphoma Patients Treated with Immunochemotherapy Who Are Alive and Progression Free 12 Months After Diagnosis Have a Subsequent Overall Survival Similar to That of the General Population

Rates and Outcomes of Follicular Lymphoma Transformation in the Rituximab Era: A Report From the University of Iowa/Mayo Clinic SPORE Molecular Epidemiology Resource

Elevated Monoclonal Free Light Chains Are a Serum Marker of ABC Type Diffuse Large B-Cell Lymphoma

Thymidylate Synthase (TS) Expression In Diffuse Large B-Cell Lymphoma (DLBCL): Identification of a Potential Therapeutic Target

Elevation of Serum Free Light Chains Are Common In Lymphoma and Associated with Poor Event Free and Overall Survival

Genetic Polymorphisms In Genes Involved In R-CHOP Metabolism and Event-Free and Overall Survival In Diffuse Large B-Cell Lymphoma

Association of Increased Thymidine Uptake Relative to Tumor Cell Proliferation in Low-Grade Follicular Lymphoma and DNA Repair.

Diffuse Large B-Cell Lymphoma (DLBCL) Patients with Composite Histology Have Improved Early Outcome Compared to De Novo DLBCL When Treated with R-CHOP

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only